Treatment of intracerebral hemorrhage: What should we do now?

Article

Abstract

Intracerebral hemorrhage (ICH) is the most lethal type of stroke. Level I, class A evidence of effective treatment is lacking. Many issues surrounding the optimal management of ICH, such as blood pressure control, prevention of hematoma growth, containing brain edema, and preserving cerebral perfusion, need more rigorous clinical research. However, when selected appropriately, the mortality of certain patients with ICH may improve when treated early with minimally invasive neurosurgery or perhaps intravenous hemostatics. In addition, patients with ICHs may have better outcome when medical care is optimized according to the published ICH treatment guidelines. Stem cell therapy has shown promise for better functional recovery.

References and Recommended Reading

  1. 1.
    Broderick J, Connolly S, Feldmann E, et al.: Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007, 38:2001–2023.PubMedCrossRefGoogle Scholar
  2. 2.
    Broderick JP, Adams HP Jr, Barsan W, et al.: Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999, 30:905–915.PubMedGoogle Scholar
  3. 3.
    Frankowski RF: Epidemiology of stroke and intracerebral hemorrhage. In Intracerebral Hematomas. Edited by Kaufman HH. New York, NY: Raven Press; 1992:1–11.Google Scholar
  4. 4.
    Russell MW, Joshi AV, Neumann PJ, et al.: Predictors of hospital length of stay and cost in patients with intracerebral hemorrhage. Neurology 2006, 67:1279–1281.PubMedCrossRefGoogle Scholar
  5. 5.
    Qureshi AI, Tuhrim S, Roderick JP, et al.: Spontaneous intracerebral hemorrhage. N Engl J Med 2001, 344:1450–1460.PubMedCrossRefGoogle Scholar
  6. 6.
    Hänggi D, Steiger HJ: Spontaneous intracerebral haemorrhage in adults: a literature overview. Acta Neurochir 2008, 150:371–379.CrossRefGoogle Scholar
  7. 7.
    Nilsson OG, Lindgren A, Stahl N, et al.: Incidence of intracerebral and subarachnoid haemorrhage in southern Sweden. J Neurol Neurosurg Psychiatry 2000, 69:601–607.PubMedCrossRefGoogle Scholar
  8. 8.
    Steiner T, Rosand J, Diringer M: Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions. Stroke 2006, 37:256–262.PubMedCrossRefGoogle Scholar
  9. 9.
    Rosand J, Eckman MH, Knudsen KA, et al.: The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 2004, 164:880–884.PubMedCrossRefGoogle Scholar
  10. 10.
    Flibotte JJ, Hagan N, O’Donnell J, et al.: Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 2004, 63:1059–1064.PubMedGoogle Scholar
  11. 11.
    Yasaka M, Minematsu K, Naritomi H, et al.: Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin. Thromb Haemost 2003, 89:278–283.PubMedGoogle Scholar
  12. 12.
    Jiang He J, Whelton PK, Vu B, et al.: Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA 1998, 280:1930–1935.CrossRefGoogle Scholar
  13. 13.
    Iso H, Jacobs DR Jr, Wentworth D, et al.: The role of statins in preventing stroke. N Engl J Med 1989, 320:904–910.PubMedGoogle Scholar
  14. 14.
    Labovitz DL, Boden-Albala B, Hauser WA, et al.: Lacunar infarct or deep intracerebral hemorrhage: who gets which? The Northern Manhattan Study. Neurology 2007, 68:606–608.PubMedCrossRefGoogle Scholar
  15. 15.
    Goldstein LB, Amarenco P, Szarek M, et al.: Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology 2008, 70:2364–2370.PubMedCrossRefGoogle Scholar
  16. 16.
    Ogasawara K, Sakai N, Kuroiwa T, et al.: Intracranial hemorrhage associated with cerebral hyperperfusion syndrome following carotid endarterectomy and carotid artery stenting: retrospective review of 4494 patients. J Neurosurg 2007, 107:1130–1136.PubMedCrossRefGoogle Scholar
  17. 17.
    Abou-Chebl A, Yadav JS, Reginelli JP, et al.: Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting: risk factors, prevention, and treatment. J Am Coll Cardiol 2004, 543:1596–1601.CrossRefGoogle Scholar
  18. 18.
    Kang HS, Han MH, Kwon OK, et al.: Intracranial hemorrhage after carotid angioplasty: a pooled analysis. J Endovasc Ther 2007, 14:77–85.PubMedCrossRefGoogle Scholar
  19. 19.
    Koennecke HC: Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology 2006, 66:165–171.PubMedCrossRefGoogle Scholar
  20. 20.
    Fazekas F, Kleinert R, Roob G, et al.: Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage. AJNR Am J Neuroradiol 1999, 20:637–642.PubMedGoogle Scholar
  21. 21.
    Kidwell CS, Chalela JA, Saver JL: Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 2004, 292:1823–1830.PubMedCrossRefGoogle Scholar
  22. 22.
    Steiner T, Kaste M, Forsting M, et al.: Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cererbovasc Dis 2006, 22:294–316.Google Scholar
  23. 23.
    Mayer SA, Brun NC, Begtrup K, et al.: Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008, 358:2127–2137.PubMedCrossRefGoogle Scholar
  24. 24.
    Mayer SA, Brun NC, Begtrup K, et al.: Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005, 352:777–785.PubMedCrossRefGoogle Scholar
  25. 25.
    Kazui S, Minematsu K, Yamamoto H, et al.: Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke 1997, 28:2370–2375.PubMedGoogle Scholar
  26. 26.
    Fujii Y, Takeuchi S, Sasaki O, et al.: Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke 1998, 29:1160–1166.PubMedGoogle Scholar
  27. 27.
    Qureshi AI, Wilson DA, Hanley DF, et al.: No evidence for an ischemic penumbra in massive experimental intracerebral hemorrhage. Neurology 1999, 52:266–272.PubMedGoogle Scholar
  28. 28.
    Zazulia AR, Diringer MN, Videen TO, et al.: Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab 2001, 12:804–810.CrossRefGoogle Scholar
  29. 29.
    Kidwell C, Saver JL, Mattiello J, et al.: Diffusion-perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage. Neurology 2001, 57:1611–1617.PubMedGoogle Scholar
  30. 30.
    Powers WJ, Zazulia AR, Videen TO: Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology 2001, 57:18–24.PubMedCrossRefGoogle Scholar
  31. 31.
    Gebel JM Jr, Janch EC, Brott TG, et al.: Natural history of perihematomal edema in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke 2002, 33:2631–2635.PubMedCrossRefGoogle Scholar
  32. 32.
    Guidelines for the Management of Severe Traumatic Brain Injury: Cerebral Perfusion Pressures. Brain Trauma Foundation: New York; 2003.Google Scholar
  33. 33.
    Feigin VL, Anderson N, Rinkel GJ, et al.: Coricosteroids for aneurysmal subarachnoid haemorrrhage and primary intracerebral haemorrhage. Cochrane Database Syst Rev 2005, (3):CD004583.Google Scholar
  34. 34.
    Thiex R, Tsirka SE: Brain edema after intracerebral hemorrhage: mechanisms, treatment options, management strategies, and operative indications. Neurosurg Focus 2007, 22:E6.PubMedCrossRefGoogle Scholar
  35. 35.
    Bereczki D, Liu M, Prado GF, Fekete I: Cochrane report: a systematic review of mannitol therapy for acute ischemic stroke and cerebral parenchymal hemorrhage. Stroke 2000, 31:2719–2722.PubMedGoogle Scholar
  36. 36.
    Koenig MA, Bryan M, Lewin JL 3rd, et al.: Reversal of trnastentorial herniation with hypertonic saline. Neurology 2008, 70:1023–1029.PubMedCrossRefGoogle Scholar
  37. 37.
    Mendelow AD, Gregson BA, Fernandes HM, et al.: Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomized trial. Lancet 2005, 9457:387–397.Google Scholar
  38. 38.
    Auer L, Deinsberger W, Niederkorn K, et al.: Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study. J Neurosurg 1989, 70:530–535.PubMedCrossRefGoogle Scholar
  39. 39.
    Teernstra OP, Evers SM, Lodder J, et al.: Stereotactic treatment of intracerebral hematoma by means of plasminogen activator: a multicenter randomized controlled trial (SICHPA). Stroke 2003, 34:968–974.PubMedCrossRefGoogle Scholar
  40. 40.
    Naval NS, Nyquist PS, Carhuapoma JR: Management of spontaneous intracerebral hemorrhage. Neurol Clin 2008, 26:373–384.PubMedCrossRefGoogle Scholar
  41. 41.
    Prasad K, Shrivastava A: Surgery for primary supratentorial intracerebral haemorrhage. Cochrane Database Syst Rev 2000, (2):CD000200.Google Scholar
  42. 42.
    ClinicalTrials.gov: Minimally Invasive Surgery Plus rtPA for Intracerebral Hemorrhage Evacuation (MISTIE). Available at http://clinicaltrials.gov/ct2/results?term=NCT00224770. Accessed November 12, 2008.
  43. 43.
    Viswanathan A, Rakich SM, Engel C, et al.: Antiplatelet use after intracerebral hemorrhage. Neurology 2006, 66:206–209.PubMedCrossRefGoogle Scholar
  44. 44.
    Eckman MH, Rosand J, Knudsen KA: Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke 2003, 34:1710–1716.PubMedCrossRefGoogle Scholar
  45. 45.
    FitzMaurice E, Wendell L, Snider R: Effect of statins on intracerebral hemorrhage outcome and recurrence. Stroke 2008, 39:2151–2154.PubMedCrossRefGoogle Scholar
  46. 46.
    Lois C, Alvarez-Buylla A: Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. Proc Natl Acad Sci U S A 1993, 90:2074–2077.PubMedCrossRefGoogle Scholar
  47. 47.
    Masuda T, Isobe Y, Aihara N, et al.: Increase in neurogenesis and neuroblast migration after a small intracerebral hemorrhage in rats. Neurosci Lett 2007, 425:114–119.PubMedCrossRefGoogle Scholar
  48. 48.
    Andres RH, Guzman R, Ducray AD, et al.: Cell replacement therapy for intracerebral hemorrhage. Neurosurg Focus 2008, 24:E15.PubMedCrossRefGoogle Scholar
  49. 49.
    Jeong SW, Chu K, Jung KH, et al.: Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage. Stroke 2003, 34:2258–2263.PubMedCrossRefGoogle Scholar
  50. 50.
    Komblum HI: Introduction to neural stem cells. Stroke 2007, 38(2 Suppl):810–816.CrossRefGoogle Scholar

Copyright information

© Current Medicine Group LLC 2009

Authors and Affiliations

  1. 1.University of Illinois College of Medicine at PeoriaPeoriaUSA

Personalised recommendations